Sun Pharma in focus after recall of product

Image
Capital Market
Last Updated : Nov 27 2017 | 9:04 AM IST

Sun Pharmaceutical Industries (Sun Pharma) said it is recalling two lots of Riomet (Metformin Hydrochloride Oral Solution), 500 mg/5ml, to the retail level (Class II Recall). This product is manufactured for SPII by a contract manufacturer. The Riomet has been found to be contaminated. The contamination was discovered during sample preparation for the Antimicrobial Preservative Effectiveness Testing (AMPET) being performed as part of the 12 month stability study interval. The announcement was made after market hours on Friday, 24 November 2017.

Future Consumer said that CARE Ratings has reaffirmed its rating assigned to the company in respect of commercial paper of Rs 100 crore at Care A1. The announcement was made after market hours on Friday, 24 November 2017.

Karnataka Bank said it has opened its 776th branch at New Delhi - Chittaranjan Park on 24 November 2017. The announcement was made after market hours on Friday, 24 November 2017.

Sadbhav Infrastructure Project said that for the first time, standalone bank facilities of the company of Rs 400 crore have been rated and it has been assigned CARE A-: Stable/CARE A2+ by ratings agency Credit Analysis & Research. The announcement was made after market hours on Friday, 24 November 2017.

GPT Infraprojects said that its subsidiary Jogbani Highway (JHPL) has been awarded a claim of about Rs 62 crore by the 3 member Arbitral Tribunal unanimously, in a dispute with the National Highways Authority of India (NHAI). The announcement was made on Saturday, 25 November 2017.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 27 2017 | 8:15 AM IST

Next Story